{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:38:00Z","timestamp":1762076280505,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ad.2018.04.011","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T01:55:41Z","timestamp":1558749341000},"page":"698-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nocardiosis cut\u00e1nea primaria en un paciente en tratamiento con certolizumab"],"prefix":"10.1016","volume":"110","author":[{"given":"R.","family":"Gil Redondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Melgar Molero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00edn Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"de Eusebio Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2018.04.011_bib0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cpt.791","article-title":"Infection risk with biologic therapy in patients with inflammatory bowel disease","volume":"102","author":"Hindryckx","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.ad.2018.04.011_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MAJ.0b013e3182883708","article-title":"Risk of nocardial infections with anti-tumor necrosis factor therapy","volume":"346","author":"Ali","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ad.2018.04.011_bib0065","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.3748\/wjg.v21.i21.6491","article-title":"Nocardia infections among immunomodulated inflammatory bowel disease patients: A review","volume":"21","author":"Abreu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ad.2018.04.011_bib0070","first-page":"2432","article-title":"Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab","volume":"32","author":"Fabre","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2018.04.011_bib0075","first-page":"195","article-title":"Nocardiosis cut\u00e1nea y sus formas cl\u00ednicas","volume":"16","author":"Guzzi","year":"2010","journal-title":"Dermatol Argent"},{"key":"10.1016\/j.ad.2018.04.011_bib0080","first-page":"75","article-title":"Primary cutaneous Nocardia brasiliensis infection isolated in an immunosuppressed patient: A case report","volume":"89","author":"Lai","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2018.04.011_bib0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01102-06","article-title":"In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods","volume":"51","author":"Cercenado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ad.2018.04.011_bib0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1503\/cmaj.1040563","article-title":"Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone","volume":"171","author":"Singh","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.ad.2018.04.011_bib0095","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site- specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ad.2018.04.011_bib0100","first-page":"75","article-title":"Primary cutaneous Nocardia brasiliensis infection isolated in an immunosuppressed patient: A case report","volume":"89","author":"Lai","year":"2012","journal-title":"Cutis"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019300626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019300626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:31:11Z","timestamp":1762075871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731019300626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0001731019300626"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2018.04.011","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nocardiosis cut\u00e1nea primaria en un paciente en tratamiento con certolizumab","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}